BILBREY JOHN P 4

What Happened

• John P. Bilbrey, a director of Colgate-Palmolive Co. (CL), received two awards on May 11, 2026: 2,075 stock units credited to a stock unit account and a grant of options covering 2,424 shares. Both items were reported as acquisitions at $0.00 on Form 4 (these are awards/grants, not open-market purchases).
• No cash changed hands for the awards at grant; the filing does not state a dollar value for the awards. The options are a derivative grant (see Key Details below) rather than an exercised option.

Key Details

• Transaction date: May 11, 2026; Form 4 filed May 13, 2026 (filed within the typical 2-business-day Form 4 window).
• Awards: 2,075 stock units (credited to a stock unit account) and options on 2,424 shares; both reported at $0.00 (grant/award code A).
• Vesting for the option grant: options become exercisable in equal annual installments over three years starting on May 11, 2027 (per footnote).
• Shares owned after the transaction: not specified in the provided report.
• Footnotes from the filing: F1 = annual director stock grant credited to a stock unit account; F2 = annual director stock option grant under the incentive plan; F3 = option vesting schedule (3 equal annual installments starting one year after grant).
• Filing timeliness: timely (no late filing indicated).

Context

• These awards are routine annual director compensation under Colgate’s incentive compensation plan and are not open-market purchases or sales. The option grant is a standard derivative award with multi-year vesting; unless exercised later and sold, it does not create immediate share sales or cash proceeds.
• For retail investors, director awards signal standard compensation practices rather than an immediate insider buy or sell.